France’s Sanofi on Monday agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion as it steps up a push in the lucrative field of cancer drugs under its new chief executive.
France’s Sanofi to buy biotech firm Synthorx for $2.5B
Source: Reuters
Business Events
Best Places to Work in PA
Thursday, December 02, 2021
Icon Honors
Tuesday, December 14, 2021
Diversity, Equity and Inclusion Summit
Wednesday, March 30, 2022
Healthcare Heroes
Thursday, April 07, 2022
